Event Registration

Summary

Do you need reliable pharmacokinetic (PK) data to evaluate human immunoglobulin or albumin-based therapeutic drug candidates? JAX offers HuPK*, a translational platform for therapeutic antibody PK evaluation. The HuPK platform features several transgenic mouse models that exclusively express human FcRn. This unique platform enables you to obtain clinically relevant PK data related to drug half-life. Additionally, our human albumin model allows assessment of conjugated therapeutics. This critically important data helps optimize the design of preclinical efficacy studies and to de-risk lead selection.

Join this webinar to learn about:

The biology of FcRn and its impact on immunoglobulin and albumin half-life
The advantages of using the HuPK platform for immunoglobulin-based therapeutic lead selection
Selecting and using specific variants of humanized FcRn models for drug evaluation
Assess PK of albumin conjugated therapeutics

*HuPK is a registered trademark in the USA and other countries

JAX™ Webinars are complimentary.
No fees will be charged for registering.

Webinars are 45-50 minutes long, followed by a Q&A session.

When registering, please use an institutional (e.g. work, university, etc.) email address or contact our event staff to request an exception. Thank you.

Translational HuPK Platform for PK/PD of Antibody & Albumin Drug Development

When registering, please use an institutional (e.g. work, university, etc.) email address or contact our event staff to request an exception. Thank you.